LSE - Delayed Quote GBp
GSK plc (GSK.L)
1,387.50
+8.50
+(0.62%)
As of 10:25:40 AM GMT+1. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
6,554,000
6,554,000
6,768,000
7,403,000
7,952,000
Investing Cash Flow
-1,229,000
-1,229,000
-1,595,000
-8,772,000
-1,777,000
Financing Cash Flow
-4,726,000
-4,726,000
-5,641,000
823,000
-7,589,000
End Cash Position
3,403,000
3,403,000
2,858,000
3,425,000
3,819,000
Capital Expenditure
-2,982,000
-2,982,000
-2,344,000
-2,258,000
-2,654,000
Issuance of Capital Stock
20,000
20,000
10,000
25,000
21,000
Issuance of Debt
1,341,000
1,341,000
223,000
2,046,000
301,000
Repayment of Debt
-2,507,000
-2,507,000
-2,593,000
-6,668,000
-2,304,000
Free Cash Flow
3,572,000
3,572,000
4,424,000
5,145,000
5,298,000
12/31/2021 - 7/1/1988
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AZN.L AstraZeneca PLC
10,306.00
-0.54%
NOVN.SW Novartis AG
91.43
+0.58%
SAN.PA Sanofi
92.20
-1.12%
BAYN.DE Bayer Aktiengesellschaft
22.28
+0.79%
ROG.SW Roche Holding AG
258.10
0.00%
AZN AstraZeneca PLC
68.51
+0.94%
NOV.DE Novo Nordisk A/S
54.07
-0.31%
PFE.DE Pfizer Inc.
19.72
+0.14%
SNY Sanofi
53.02
+2.26%
NVS Novartis AG
110.13
-1.15%